Pfizer Inc. (PFE) reported a rise in earnings for the second quarter, helped by the strength of its anchor brands, primarily Ibrance,
Categories
Other Industries
Transocean posts smaller than expected Q2 loss
Transocean Ltd (RIG) continued its losing streak that began more than a year ago and posted a narrower than expected loss in
ON Semiconductor reports upbeat Q2 results
ON Semiconductor (ON) reported a 65% jump in earnings for the second quarter as increasing demand for its products drove revenue higher
Loews misses Q2 earnings estimate
Insurance firm Loews Corp. (L) saw its stock trade 1% down Monday after it posted second-quarter earnings that missed analysts estimates. Net
Caterpillar stock climbs on upbeat results and boosted outlook
Caterpillar (CAT) beat estimates for the second quarter and raised its outlook for the year sending the stock upward by more than
Qualcomm ends two-year struggle to acquire NXP
The speculations revolving Qualcomm - NXP Semiconductors takeover has finally been put to rest after the US chipmaker officially terminated the deal
Phillips 66 posts upbeat earnings in Q2
Phillips 66 (PSX) reported revenues of $29.7 billion for the second quarter of 2018, up 23% from the same period last year.
Colgate-Palmolive shares dip on Q2 revenue miss
Colgate-Palmolive (CL) stock declined more than 2% during the premarket trading, after the toothpaste maker's second-quarter sales missed analysts' expectations, primarily due
Overseas sales boost Under Armour topline in Q2
On Thursday, Under Armour (UA, UAA) witnessed a surge in its share price after the company beat top-line estimates during its second-quarter.
Chevron earnings rise on production spike, but miss street view
Strong production growth and the oil price boom lifted Chevron’s (CVX) profit in the second quarter. Earnings, however, missed analysts’ forecast and
Exxon Mobil shares fall on Q2 earnings miss
Oil and gas company Exxon Mobil (XOM) witnessed a 3% drop in its share price after it missed analysts' earnings estimate in
Merck posts upbeat Q2 results
Pharma giant Merck (MRK) reported a 12.4% dip in earnings for the second quarter as higher costs offset a dip in income
Expedia stock surges on topping estimates in Q2
Online travel services provider Expedia Group (EXPE) reported lower profits in the second-quarter of 2018, primarily hurt by increased marketing spending. Early
New drug sales power Amgen’s Q2 results
In the midst of Amgen (AMGN) facing intense competition for its blockbuster products from its rivals, the pharma company posted better-than-expected second-quarter
Celgene stock rises on upbeat Q2 results, lifts outlook
Troubled pharma company Celgene (CELG) posted Q2 results beating analysts’ view and also lifted its earnings outlook for 2018. Shares of Celgene
Allergan posts upbeat results on higher Botox, Juvederm sales
Allergan’s (AGN) revenue and adjusted EPS figures for Q2 beat market estimates, sending shares up by about 0.7% in premarket trade. The
Alexion Pharmaceutical sales spike by 14% in Q2
Alexion Pharmaceutical Thursday reported 14% increase in revenue for the second quarter, riding on a 16% volume hike. The company, however, swung
Spotify’s family plan boosts subscriber growth in Q2
Music streaming giant Spotify (SPOT) released its second-ever earnings report in which, it posted a wider loss of EUR 2.20 per share
Upbeat Q2 results no help to Gilead Sciences as CEO resignation sends shares down
Lower product sales and prescription trends continued to batter Gilead Sciences (GILD), as earnings slipped more than 40% in the second quarter
General Dynamics reports solid revenue and earnings growth in Q2
General Dynamics (GD) beats revenue and earnings estimates for the second quarter 2018. Despite earnings and revenue topping the estimates, the stock
Boeing’s strong aircraft deliveries lift Q2 results
Boeing (BA) reported a 26% jump in earnings for the second quarter as higher commercial deliveries and defense contract volume drove revenue